<?xml version="1.0" encoding="UTF-8" ?>
<modsCollection xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" xmlns:slims="http://senayan.diknas.go.id" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd">
<mods version="3.3" ID="2031">
<titleInfo>
<title>Marmara Pharmaceutical Journal of Research in Pharmacy Journal of Research in Pharmacy 2024 , Vol 28 , Issue 3</title>
</titleInfo>
<typeOfResource manuscript="yes" collection="yes">mixed material</typeOfResource>
<genre authority="marcgt">bibliography</genre>
<originInfo>
<place><placeTerm type="text"></placeTerm></place>
<publisher>marmara University</publisher>
<dateIssued>2024</dateIssued>
<issuance>monographic</issuance>
<edition>2024 , Vol 28 , Issue 3</edition>
</originInfo>
<language>
<languageTerm type="code">id</languageTerm>
<languageTerm type="text">Indonesia</languageTerm>
</language>
<physicalDescription>
<form authority="gmd">Karya Tulis Ilmiah</form>
<extent></extent>
</physicalDescription>
<note>ABSTRACT: The combination of entecavir (ETV) and tenofovir (TEV), nucleos(t)ide analogs (NUCs), is advised as first-
line treatment for people suffering from multidrug-resistant hepatitis B due to their favorable safety profile, low side-
effect rate, and high genetic barrier. This study reports the fabrication of a novel cross-linked ethylenediamine

sulfonamide polymer resin (EDASP) and graphene (Gr)-modified carbon paste electrodes (CPE) for the simultaneous
determination of the anti-HBV drugs ETV and TEV in bulk and dosage form by differential pulse voltammetry (DPV).
The electrodes were specified through cyclic voltammetry, Fourier transform infrared (FTIR), scanning electron
microscopy (SEM), and the analytical parameters were optimized. The findings indicate that both drugs displayed clear
oxidation peaks on the Gr-CPE and EDASP-CPE electrodes at pH 4.5 and 4.0, respectively, in the Britton-Robinson
buffer. The linear dynamic range of ETV and TEV was determined between 1&mu;M and 250&mu;M on both working electrodes
by DPV. The limit of detection (LOD) and limit of quantification (LOQ) for ETV were 0.2&mu;M and 0.6&mu;M, respectively,
on Gr-CPE. The LOD and LOQ for TEV were 0.2&mu;M and 0.7&mu;M, respectively. The novel EDASP-CPE exhibited
improved sensitivity with LOD and LOQ for ETV of 0.2&mu;M and 0.5&mu;M, respectively. The LOD and LOQ for TEV on
EDASP CPE were 0.2&mu;M and 0.7&mu;M, respectively. The proposed method was successfully applied to the simultaneous
determination of ETV and TEV in a commercial tablet dosage form, exhibiting good accuracy and precision. The results
highlight the potential of the novel cross-linked ethylenediamine sulfonamide polymer resin-modified carbon paste
electrode for the simultaneous determination of anti-HBV drugs in dosage form by differential pulse voltammetry.

KEYWORDS: Tenofovir, entecavir, ethylenediamine sulfonamide polymer resin, graphene, modified carbon paste
electrode, voltammetry, pharmaceutical preparation.</note>
<subject authority=""><topic>voltammetry</topic></subject>
<subject authority=""><topic>graphene</topic></subject>
<subject authority=""><topic>ethylenediamine sulfonamide polymer resin</topic></subject>
<subject authority=""><topic>entecavir</topic></subject>
<subject authority=""><topic>Tenofovir</topic></subject>
<classification></classification><identifier type="isbn"></identifier><location>
<physicalLocation>PERPUSTAKAAN SEKOLAH TINGGI ILMU KESEHATAN SAMARINDA REPOSITORY</physicalLocation>
<shelfLocator></shelfLocator>
<holdingSimple>
<copyInformation>
<numerationAndChronology type="1">JIN0111</numerationAndChronology>
<sublocation>Perpus.Akfarsam (Jurnal Internasioan)</sublocation>
<shelfLocator>615 MAR b</shelfLocator>
</copyInformation>
</holdingSimple>
</location>
<slims:digitals>
<slims:digital_item id="2112" url="https://drive.google.com/file/d/1uaWCerYXmQsR-w38mKDMGuV1N09FPYqg/view?usp=sharing" path="/https://drive.google.com/file/d/1uaWCerYXmQsR-w38mKDMGuV1N09FPYqg/view?usp=sharing" mimetype="text/uri-list">Marmara Pharmaceutical Journal of Research in Pharmacy Journal of Research in Pharmacy 2024 , Vol 28 , Issue 3</slims:digital_item>
</slims:digitals><recordInfo>
<recordIdentifier>2031</recordIdentifier>
<recordCreationDate encoding="w3cdtf">2025-01-30 14:00:40</recordCreationDate>
<recordChangeDate encoding="w3cdtf">2025-01-30 14:03:55</recordChangeDate>
<recordOrigin>machine generated</recordOrigin>
</recordInfo></mods></modsCollection>